No effects of quaternary neuroleptics on human prolactin and adenylcyclase

Genomic basis of developmental defects of enamel and sex-specific effects.

medRxiv : the preprint server for health sciences·2026

A new Li/Mg paleothermometer from pteropod shells.

Scientific reports·2026

Multiancestry Genome-Wide Association Study of Early Childhood Caries.

Journal of dental research·2024

Multi-ancestry Genome-Wide Association Study of Early Childhood Caries.

medRxiv : the preprint server for health sciences·2024

Unexpected silicon localization in calcium carbonate exoskeleton of cultured and fossil coccolithophores.

Scientific reports·2023

Comparison of sentinel lymph node biopsy and elective neck dissection for early oral cavity squamous cell carcinoma patients with clinically node-negative necks: systematic review and meta-analysis.

The Journal of laryngology and otology·2022

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

A Single Suprachoroidal Injection of AXT107 (Gersizangitide), a Multimodal, Long-Acting Integrin-Disrupting Peptide, in Patients with Neovascular Age-Related Macular Degeneration: Results of the Phase 1/2a DISCOVER Trial.

medRxiv : the preprint server for health sciences·2026

Postnatal Development Shapes the Cardiac Response to Milrinone.

bioRxiv : the preprint server for biology·2026

Related Experiment Videos

No effects of quaternary neuroleptics on human prolactin and adenylcyclase

Related Concept Videos

Genomic basis of developmental defects of enamel and sex-specific effects.

A new Li/Mg paleothermometer from pteropod shells.

Multiancestry Genome-Wide Association Study of Early Childhood Caries.

Multi-ancestry Genome-Wide Association Study of Early Childhood Caries.

Unexpected silicon localization in calcium carbonate exoskeleton of cultured and fossil coccolithophores.

Comparison of sentinel lymph node biopsy and elective neck dissection for early oral cavity squamous cell carcinoma patients with clinically node-negative necks: systematic review and meta-analysis.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

A Single Suprachoroidal Injection of AXT107 (Gersizangitide), a Multimodal, Long-Acting Integrin-Disrupting Peptide, in Patients with Neovascular Age-Related Macular Degeneration: Results of the Phase 1/2a DISCOVER Trial.

Postnatal Development Shapes the Cardiac Response to Milrinone.

Related Experiment Videos

No effects of quaternary neuroleptics on human prolactin and adenylcyclase

Related Concept Videos

Related Articles